These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2436011)
1. Effect of a purified amylase inhibitor on carbohydrate metabolism after a mixed meal in healthy humans. Boivin M; Zinsmeister AR; Go VL; DiMagno EP Mayo Clin Proc; 1987 Apr; 62(4):249-55. PubMed ID: 2436011 [TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal and metabolic effects of amylase inhibition in diabetics. Boivin M; Flourie B; Rizza RA; Go VL; DiMagno EP Gastroenterology; 1988 Feb; 94(2):387-94. PubMed ID: 2446948 [TBL] [Abstract][Full Text] [Related]
3. Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitus. Layer P; Rizza RA; Zinsmeister AR; Carlson GL; DiMagno EP Mayo Clin Proc; 1986 Jun; 61(6):442-7. PubMed ID: 2423813 [TBL] [Abstract][Full Text] [Related]
4. Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Layer P; Zinsmeister AR; DiMagno EP Gastroenterology; 1986 Jul; 91(1):41-8. PubMed ID: 2423408 [TBL] [Abstract][Full Text] [Related]
5. Impairment of starch absorption by a potent amylase inhibitor. Brugge WR; Rosenfeld MS Am J Gastroenterol; 1987 Aug; 82(8):718-22. PubMed ID: 2440298 [TBL] [Abstract][Full Text] [Related]
6. Carbohydrate digestion and release of pancreatic polypeptide in health and diabetes mellitus. Layer P; Go VL; DiMagno EP Gut; 1989 Sep; 30(9):1279-84. PubMed ID: 2478426 [TBL] [Abstract][Full Text] [Related]
7. Acute postprandial gastrointestinal and metabolic effects of wheat amylase inhibitor (WAI) in normal, obese, and diabetic humans. Lankisch M; Layer P; Rizza RA; DiMagno EP Pancreas; 1998 Aug; 17(2):176-81. PubMed ID: 9700950 [TBL] [Abstract][Full Text] [Related]
8. Effect of a wheat amylase inhibitor on canine carbohydrate digestion, gastrointestinal function, and pancreatic growth. Koike D; Yamadera K; DiMagno EP Gastroenterology; 1995 Apr; 108(4):1221-9. PubMed ID: 7535274 [TBL] [Abstract][Full Text] [Related]
9. Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans. Layer P; Carlson GL; DiMagno EP Gastroenterology; 1985 Jun; 88(6):1895-902. PubMed ID: 2581844 [TBL] [Abstract][Full Text] [Related]
10. Control of postprandial hyperglycaemia by galactosyl maltobionolactone and its novel anti-amylase effect in mice. Murai A; Iwamura K; Takada M; Ogawa K; Usui T; Okumura J Life Sci; 2002 Aug; 71(12):1405-15. PubMed ID: 12127161 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release. Enç FY; Imeryüz N; Akin L; Turoğlu T; Dede F; Haklar G; Tekeşin N; Bekiroğlu N; Yeğen BC; Rehfeld JF; Holst JJ; Ulusoy NB Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G752-63. PubMed ID: 11518688 [TBL] [Abstract][Full Text] [Related]
12. A bean alpha-amylase inhibitor formulation (starch blocker) is ineffective in man. Carlson GL; Li BU; Bass P; Olsen WA Science; 1983 Jan; 219(4583):393-5. PubMed ID: 6184780 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the pattern of postprandial carbohydrate metabolism after ingestion of a glucose drink or a mixed meal. McMahon M; Marsh H; Rizza R J Clin Endocrinol Metab; 1989 Mar; 68(3):647-53. PubMed ID: 2645312 [TBL] [Abstract][Full Text] [Related]
14. Acute metabolic response to high-carbohydrate, high-starch meals compared with moderate-carbohydrate, low-starch meals in subjects with type 2 diabetes. Gannon MC; Nuttall FQ; Westphal SA; Fang S; Ercan-Fang N Diabetes Care; 1998 Oct; 21(10):1619-26. PubMed ID: 9773720 [TBL] [Abstract][Full Text] [Related]
15. Starch blockers--their effect on calorie absorption from a high-starch meal. Bo-Linn GW; Santa Ana CA; Morawski SG; Fordtran JS N Engl J Med; 1982 Dec; 307(23):1413-6. PubMed ID: 6182469 [TBL] [Abstract][Full Text] [Related]
16. Effects of a commercial starch blocker preparation on carbohydrate digestion and absorption: in vivo and in vitro studies. Hollenbeck CB; Coulston AM; Quan R; Becker TR; Vreman HJ; Stevenson DK; Reaven GM Am J Clin Nutr; 1983 Oct; 38(4):498-503. PubMed ID: 6414283 [TBL] [Abstract][Full Text] [Related]
17. Effect of source of dietary carbohydrate on plasma glucose, insulin, and gastric inhibitory polypeptide responses to test meals in subjects with noninsulin-dependent diabetes mellitus. Coulston AM; Hollenbeck CB; Liu GC; Williams RA; Starich GH; Mazzaferri EL; Reaven GM Am J Clin Nutr; 1984 Nov; 40(5):965-70. PubMed ID: 6388305 [TBL] [Abstract][Full Text] [Related]
18. Effects of lipase inhibition on gastric emptying of, and on the glycaemic, insulin and cardiovascular responses to, a high-fat/carbohydrate meal in type 2 diabetes. O'Donovan D; Horowitz M; Russo A; Feinle-Bisset C; Murolo N; Gentilcore D; Wishart JM; Morris HA; Jones KL Diabetologia; 2004 Dec; 47(12):2208-14. PubMed ID: 15662558 [TBL] [Abstract][Full Text] [Related]
19. Postruminal digestion of starch infused into the abomasum of heifers with or without exogenous amylase administration. Westreicher-Kristen E; Robbers K; Blank R; Tröscher A; Dickhoefer U; Wolffram S; Susenbeth A J Anim Sci; 2018 May; 96(5):1939-1951. PubMed ID: 29617812 [TBL] [Abstract][Full Text] [Related]
20. Determination of glycaemic index; some methodological aspects related to the analysis of carbohydrate load and characteristics of the previous evening meal. Granfeldt Y; Wu X; Björck I Eur J Clin Nutr; 2006 Jan; 60(1):104-12. PubMed ID: 16205745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]